IS8705A - Kristallaður basi af essítalóprami og munndreifitöflur sem samanstanda af essítalópram basa - Google Patents

Kristallaður basi af essítalóprami og munndreifitöflur sem samanstanda af essítalópram basa

Info

Publication number
IS8705A
IS8705A IS8705A IS8705A IS8705A IS 8705 A IS8705 A IS 8705A IS 8705 A IS8705 A IS 8705A IS 8705 A IS8705 A IS 8705A IS 8705 A IS8705 A IS 8705A
Authority
IS
Iceland
Prior art keywords
acitalopram
base
orodispersible tablets
crystalline
tablets consisting
Prior art date
Application number
IS8705A
Other languages
English (en)
Icelandic (is)
Inventor
Dancer Robert
Petersen Hans
Nielsen Ole
Harold Rock Michael
Eliasen Helle
Liljegren Ken
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37546630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8705(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS8705A publication Critical patent/IS8705A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B63/00—Purification; Separation; Stabilisation; Use of additives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS8705A 2005-06-22 2008-01-14 Kristallaður basi af essítalóprami og munndreifitöflur sem samanstanda af essítalópram basa IS8705A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200500912 2005-06-22
PCT/DK2006/000366 WO2006136169A2 (en) 2005-06-22 2006-06-22 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base

Publications (1)

Publication Number Publication Date
IS8705A true IS8705A (is) 2008-01-14

Family

ID=37546630

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8705A IS8705A (is) 2005-06-22 2008-01-14 Kristallaður basi af essítalóprami og munndreifitöflur sem samanstanda af essítalópram basa

Country Status (39)

Country Link
EP (3) EP1896439B2 (2)
JP (5) JP4906852B2 (2)
KR (5) KR20110084341A (2)
CN (2) CN101189220A (2)
AR (2) AR055062A1 (2)
AT (3) AT10983U1 (2)
AU (2) AU2006261452B2 (2)
BG (1) BG66086B1 (2)
BR (1) BRPI0612295A2 (2)
CA (2) CA2612827C (2)
CY (1) CY1112392T1 (2)
CZ (3) CZ299906B6 (2)
DE (2) DE602006019961D1 (2)
DK (3) DK1896439T4 (2)
EA (2) EA201001108A1 (2)
EE (1) EE00773U1 (2)
ES (2) ES2319073B1 (2)
FI (2) FI20080548A7 (2)
GB (2) GB2442160B (2)
HR (1) HRP20110093T4 (2)
HU (1) HUP0800135A3 (2)
IL (1) IL187454A0 (2)
IS (1) IS8705A (2)
LT (1) LT5550B (2)
LV (1) LV13677B (2)
MX (1) MX2007015328A (2)
MY (2) MY143239A (2)
NO (2) NO20080359L (2)
PL (2) PL1896439T5 (2)
PT (1) PT1896439E (2)
RS (1) RS51575B2 (2)
SG (1) SG169358A1 (2)
SI (1) SI1896439T2 (2)
SK (1) SK500402007A3 (2)
TR (2) TR201000625T1 (2)
TW (2) TWI347942B (2)
UA (1) UA86536C2 (2)
WO (1) WO2006136169A2 (2)
ZA (2) ZA200711066B (2)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
WO2008104880A2 (en) * 2007-03-01 2008-09-04 Aurobindo Pharma Limited Stable solid dosage forms of an antidepressant
EP2595979B1 (en) 2010-07-23 2016-04-06 H. Lundbeck A/S Process for the purification of pharmaceutically acceptable salts of escitalopram
CN103360353A (zh) * 2013-08-07 2013-10-23 中国药科大学 草酸艾司西酞普兰杂质的制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
WO2018190294A1 (ja) * 2017-04-10 2018-10-18 東和薬品株式会社 エスシタロプラム医薬組成物
CN110711198B (zh) * 2018-07-12 2022-03-15 山东大学 D-甘露糖在制备抗抑郁药物中的应用
KR102331187B1 (ko) 2019-04-09 2021-11-26 주식회사 라이트팜텍 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
JPH05222041A (ja) * 1992-02-13 1993-08-31 Mitsubishi Gas Chem Co Inc アデニン誘導体の精製法
WO1995020377A1 (en) * 1994-01-27 1995-08-03 The Board Of Regents Of The University Of Oklahoma Rapidly dissolving oral dosage form
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
EP0993524B1 (en) 1997-06-30 2002-11-20 Beloit Technologies, Inc. Method and apparatus for the high speed application of coating to a traveling paper web
ES2148120T3 (es) 1997-07-08 2002-01-16 Lundbeck & Co As H Metodo para la preparacion de citalopram.
EA002770B1 (ru) 1997-11-11 2002-08-29 Х.Лундбекк А/С Способ получения циталопрама
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
US20020071864A1 (en) * 1999-03-25 2002-06-13 Yuhan Corporation Rapidly disintegrable tablet for oral administration
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
WO2002030400A1 (fr) * 2000-10-06 2002-04-18 Takeda Chemical Industries, Ltd. Preparations solides
KR20030042006A (ko) * 2000-10-16 2003-05-27 다이이찌 세이야꾸 가부시기가이샤 구강내 속붕괴성 의약 조성물 및 그의 제조방법
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
WO2001045483A2 (en) * 2000-12-22 2001-06-28 H. Lundbeck A/S Method for the preparation of pure citalopram
JP2003519121A (ja) * 2000-12-28 2003-06-17 ハー・ルンドベック・アクチエゼルスカベット 純粋なシタロプラムの製造方法
WO2002087566A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
GB0113842D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR034759A1 (es) 2001-07-13 2004-03-17 Lundbeck & Co As H Metodo para la preparacion de escitalopram
IL159326A0 (en) * 2001-07-31 2004-06-01 Lundbeck & Co As H Crystalline composition containing escitalopram
IS7239A (is) 2001-12-14 2004-04-29 H. Lundbeck A/S Aðferð til framleiðslu á essítalóprami
US7148364B2 (en) * 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
EP1517676A1 (en) * 2002-05-03 2005-03-30 Skyepharma Canada Inc. Oral dosage forms comprising fenofibrate
AU2003287919B2 (en) 2002-12-23 2009-11-12 H. Lundbeck A/S Escitalopram hydrobromide and a method for the preparation thereof
CN1510024A (zh) * 2002-12-24 2004-07-07 北京德众万全药物技术开发有限公司 可用于制备西酞普兰(s)-对映异构体的新的化合物及其制备方法
DE10305984A1 (de) * 2003-02-13 2004-09-02 Helm Ag Salze organischer Säuren mit Clopidogrel und deren Verwendung zur Herstellung phamazeutischer Formulierungen
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
US8647668B2 (en) * 2003-10-15 2014-02-11 Fuji Chemical Industry Co., Ltd. Tablet quickly disintegrating in oral cavity
WO2005049596A1 (en) * 2003-11-20 2005-06-02 Natco Pharma Limited A process for the preparation of high purity escitalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2005084643A1 (en) * 2004-03-05 2005-09-15 H. Lundbeck A/S Crystalline composition containing escitalopram oxalate
EP1877394A1 (en) * 2005-04-04 2008-01-16 Jubilant Organosys Limited Process for the preparation of escitalopram or its acid addition salts

Also Published As

Publication number Publication date
IL187454A0 (en) 2008-02-09
SG169358A1 (en) 2011-03-30
SK500402007A3 (sk) 2008-05-06
ZA200901698B (en) 2010-04-28
CA2612827C (en) 2010-11-30
GB2448834B (en) 2010-01-20
TR200708792T1 (tr) 2008-05-21
LT2008005A (en) 2008-10-27
FI20077133L (fi) 2007-12-20
AR079750A2 (es) 2012-02-15
TR201000625T1 (tr) 2010-03-22
AT11883U1 (de) 2011-06-15
JP4415056B2 (ja) 2010-02-17
NO20080359L (no) 2008-01-18
DK1896439T4 (en) 2015-01-12
GB2442160A (en) 2008-03-26
AT10983U1 (de) 2010-02-15
CZ2007898A3 (cs) 2008-01-23
KR20100133023A (ko) 2010-12-20
RS51575B2 (sr) 2018-02-28
FI20080548L (fi) 2008-10-07
GB0811164D0 (en) 2008-07-23
EP2385044A1 (en) 2011-11-09
UA86536C2 (ru) 2009-04-27
EP1896439B2 (en) 2014-10-15
KR101340815B1 (ko) 2013-12-11
WO2006136169A2 (en) 2006-12-28
EP1896439B1 (en) 2011-02-02
BRPI0612295A2 (pt) 2011-01-04
ES2319073B1 (es) 2010-02-26
PL384185A1 (pl) 2008-06-23
MY143239A (en) 2011-04-15
ATE497500T1 (de) 2011-02-15
GB0724557D0 (en) 2008-01-23
JP4906852B2 (ja) 2012-03-28
JP2009046506A (ja) 2009-03-05
EP2325177A1 (en) 2011-05-25
JP2009179635A (ja) 2009-08-13
CA2612827A1 (en) 2006-12-28
TWI358407B (en) 2012-02-21
EA201001108A1 (ru) 2011-02-28
CZ300686B6 (cs) 2009-07-15
JP2008546724A (ja) 2008-12-25
ZA200711066B (en) 2009-07-29
HUP0800135A2 (en) 2008-06-30
EE00773U1 (et) 2008-10-15
SI1896439T2 (sl) 2014-12-31
GB2448834A (en) 2008-10-29
TWI347942B (en) 2011-09-01
AR055062A1 (es) 2007-08-01
DE112006001619T5 (de) 2008-06-12
HRP20110093T4 (hr) 2015-02-27
JP2012072168A (ja) 2012-04-12
AU2006261452A1 (en) 2006-12-28
DK200900284A (da) 2009-02-27
ES2319073A1 (es) 2009-05-01
FI20080548A7 (fi) 2008-10-07
HUP0800135A3 (en) 2009-01-28
KR20110084341A (ko) 2011-07-21
PL1896439T5 (pl) 2016-01-29
KR20110033310A (ko) 2011-03-30
TW200740785A (en) 2007-11-01
LT5550B (lt) 2009-03-25
EA019239B1 (ru) 2014-02-28
MY143252A (en) 2011-04-15
ES2356838T5 (es) 2015-01-26
GB2442160B (en) 2010-01-20
AU2010200844A1 (en) 2010-04-01
RS51575B (sr) 2011-08-31
DK1896439T3 (da) 2011-02-28
KR20120064140A (ko) 2012-06-18
TW201130808A (en) 2011-09-16
PT1896439E (pt) 2011-02-15
CN101928269A (zh) 2010-12-29
ES2356838T3 (es) 2011-04-13
SI1896439T1 (sl) 2011-03-31
KR20080018191A (ko) 2008-02-27
CY1112392T1 (el) 2015-12-09
HRP20110093T1 (hr) 2011-03-31
EP1896439A2 (en) 2008-03-12
MX2007015328A (es) 2008-02-15
CA2646780A1 (en) 2006-12-28
PL1896439T3 (pl) 2011-04-29
LV13677B (en) 2008-05-20
EA200800102A1 (ru) 2008-04-28
NO20101777L (no) 2008-01-18
BG66086B1 (bg) 2011-03-31
WO2006136169A3 (en) 2007-10-18
CZ299906B6 (cs) 2008-12-29
CZ301286B6 (cs) 2009-12-30
JP5731957B2 (ja) 2015-06-10
DE602006019961D1 (de) 2011-03-17
AU2006261452B2 (en) 2010-02-04
BG110024A (bg) 2008-05-30
CN101189220A (zh) 2008-05-28
DK200800075A (da) 2008-03-15
FI20077133A7 (fi) 2007-12-20
JP2009179634A (ja) 2009-08-13

Similar Documents

Publication Publication Date Title
IS8705A (is) Kristallaður basi af essítalóprami og munndreifitöflur sem samanstanda af essítalópram basa
NO2019033I1 (no) regorafenib
EP1824427A4 (en) BETWEEN FACET IMPLANT
DK1883665T3 (da) Polylactidsammensætninger og anvendelser deraf
DE602005011124D1 (de) Knochenverankerungselement
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
ITMI20041571A1 (it) Perfluoroelastomeri
DK3321359T3 (da) Variante former af uratoxidase og anvendelse deraf
DE602006002662D1 (de) Knochen- Verankerungselement
DE602005002247D1 (de) Lautsprecher
ATE405943T1 (de) Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
EP1760098A4 (en) BIOKOMPATIBLE MATERIAL
DE602005024018D1 (de) Lautsprecher
PL1858481T3 (pl) Kompozycje oftalmologiczne i ich zastosowanie
GB0720564D0 (en) Circuit materials circuits and methods of manufacture thereof
DE602005005269D1 (de) geformter Artikel
FR2887144B3 (fr) Audio vibromasseur
DE202005000325U1 (de) Lautsprecher
FR2884138B1 (fr) Implants visses
PT9959T (pt) Elemento base de construcao de mobiliario
ATE497743T1 (de) Expandierbares bandscheibenimplantat
FR2894782B1 (fr) Implant capillaire
DE10394322D2 (de) Schmuckstück
ITPI20050003A1 (it) Base di sostegno
SE0400213D0 (sv) Diurea Derivatives